Bal Pharma Limited (NSE:BALPHARMA)

Bal Pharma Revenue

In the fiscal year ending March 31, 2026, Bal Pharma had annual revenue of 3.12B INR with 2.83% growth. Bal Pharma had revenue of 840.76M in the quarter ending March 31, 2026, with 2.69% growth.

• Revenue: 3.12B
• Revenue Growth: +2.83%
• P/S Ratio: 0.44
• Revenue / Employee: 3.16M
• Employees: 986
• Market Cap: 1.39B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	3.12B	85.78M	2.83%
Mar 31, 2025	3.03B	-361.36M	-10.65%
Mar 31, 2024	3.39B	350.03M	11.51%
Mar 31, 2023	3.04B	230.02M	8.18%
Mar 31, 2022	2.81B	306.86M	12.25%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 17, 2026

Data Sources Report a data error